Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.


The European Association of Urology and Elsevier are proud to present URO ONCO, the online educational platform for all healthcare professionals in uro-oncology.

URO ONCO provides up-to-date information on developments in the field of urological malignancies. With urological tumours presenting three of the ten most commonly found cancers, the need for up-to-date cancer management knowledge is essential for urologists

Latest Headlines in Prostate

Latest Headlines in Bladder

  • Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer

    Rose TL, Deal AM, Ladoire S, Créhange G, Galsky MD, Rosenberg JE, et al.

    Bladder Cancer. 2016 Oct 27;2(4):405-413. doi: 10.3233/BLC-160072.

    Editorial comment from Piotr Chlosta:
    In clinical practice, BPT patients have similar survival to RC patients when treated with curative radiotherapy doses. Choice of concurrent chemotherapy regimen varied widely with no clear standard.

  • Muscle-invasive bladder cancer: Molecular subtypes and response to neoadjuvant chemotherapy

    R. Seiler, B. Winters, J. Douglas, B. van Rhijn, G. Sjödahl, S. Lerner, et al.

    J Clin Oncol 35, 2017 (Suppl 6S; abstract 281)

    Editorial comment from Prof. Piotr Chlosta:
    Benefit of cisplatin based neoadjuvant chemotherapy varied depending on molecular subtype of bladder cancer. NAC (compared to surgery alone) was associated with improvement in prognosis in basal subtype, while there was no improvement for other subtypes. Results suggest that molecular subtyping may help in selecting patients who could benefit most from NAC, and patients who could be best managed with surgery alone. 

  • Effect of contrast media on urinary cytopathology specimens

    S. Frees, S. Bidnur, M. Metcalfe, P. Raven, C. Chavez-Munoz, I. Moskalev, et al.

    Can Urol Assoc J. 2016 Aug; 10(7-8): 228–233 ABSTRACT: Introduction: Urological dogma dictates that washings collected from the urinary tract...

    Editorial comment from Piotr Chlosta:
    Study suggests that commonly used contrast agents do not alter urothelial cell morphology and do not impair cytopathological analysis when fixation is within 5 minutes following exposure, questioning common recommendation of collecting washings from urinary tract before contrast agent administration.

Latest Headlines in Kidney

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre


EAU 2017 Scientific Programme and Sessions

View the Scientific Programme and Sessions of the 2017 EAU Annual Congress, Munich, Germany.

Congress Planner

EAU Guidelines


URO ONCO is made possible by an unrestricted educational grant from:

  Janssen Pharmaceutical Companies